Sorafenib in combination with gemcitabine in recurrent epithelial ovarian cancer: a study of the Princess Margaret Hospital Phase II Consortium (Q42905241)

From Wikidata
Jump to navigation Jump to search
scientific article published on July 2010
edit
Language Label Description Also known as
English
Sorafenib in combination with gemcitabine in recurrent epithelial ovarian cancer: a study of the Princess Margaret Hospital Phase II Consortium
scientific article published on July 2010

    Statements

    Sorafenib in combination with gemcitabine in recurrent epithelial ovarian cancer: a study of the Princess Margaret Hospital Phase II Consortium (English)
    Stephen A Welch
    Hal W Hirte
    Laurie Elit
    Russel J Schilder
    Lisa Wang
    Katrina Macalpine
    John J Wright
    Amit M Oza
    1 July 2010
    787-793

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit